NCT05744921: A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
- State
- Under way
- Phase
- Phase 3
- People
- 202 planned
- Started
- 7 Mar 2023
- Primary completion
- 10 Oct 2028
- Arms
- PNH Transition Patients, C5 Polymorphism Patients
- Results
- None posted
- 27 Feb 2023: Trial registered
- 7 Mar 2023: Trial started